Found 60 matching trials
ITIL-168 in Advanced Solid Tumors
PHASE1DELTA-2 is a phase 1 clinical trial to evaluate the safety, feasibility, an...
Location
Multiple Locations
A Clinical Study on TILs for the Treatment of Advanced Solid Tumors
EARLY_PHASE1This study is an open exploratory clinical study to evaluate the safety, to...
Location
Multiple Locations
A Study of GC101 TIL in Advanced Solid Tumors (TR)
EARLY_PHASE1This study is to investigate the safety and efficacy of tumor infiltrating ...
Location
Tongren Hospital Shanghai Jiao Tong University School Of Medicine.
Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors
PHASE1To determine whether special tumor fighting cells that is taken from partic...
Location
UC San Diego Moores Cancer Center
Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1
PHASE1This phase I/IIa trial studies the side effects and best dose of gene-modif...
Status
Active Not Recruiting
Location
Roswell Park Cancer Institute
A Clinical Study on TIL for the Treatment of Advanced Solid Tumors
EARLY_PHASE1This study is to investigate the safety and efficacy of tumor infiltrating ...
Location
Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine
Study of GC101 TIL in Brain Glioma (Soochow2)
EARLY_PHASE1This study is to investigate the safety and efficacy of tumor infiltrating ...
Location
The Second Affiliated Hospital of Soochow University
Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
PHASE1This research study aims to evaluate the safety and effectiveness of a nove...
Location
AHN West Penn Hospital
A Study of GC101 TIL in Advanced Breast Cancer (10hospital)
EARLY_PHASE1This study is to investigate the safety and efficacy of tumor infiltrating ...
Location
Shanghai Tenth People's Hospital
An Exploratory Clinical Study of TILs in the Treatment of Recurrent / Refractory Non-small Cell Lung Cancer (NSCLC)
EARLY_PHASE1This study is an open, single-arm, dose-escalating phase I exploratory clin...
Location
Multiple Locations